Products - COVID-19 | Topic | NICE

Showing 7 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter
Status: Awaiting developmentRemove ‘Status: Awaiting development’ filter

COVID-19 technology appraisal recommendations: surveillance and rapid update process statement consultation
Status:
In development
Programme:
NICE general
Expected publication date:
TBC
Ensitrelvir for treating COVID-19 [ID6231]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Exploratory economic modelling of SARS-CoV-2 viral detection point of care tests and serology tests
Status:
In development
Programme:
Diagnostics guidance
Expected publication date:
TBC
Remdesivir for treating COVID-19 [ID3808]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Sabizabulin for treating COVID-19 [TSID11814]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Sipavibart for preventing COVID-19 [ID6282]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Vilobelimab for treating COVID-19 [TSID11815]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC